Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Embecta Corp. before investing.

In this article, we go over a few key elements for understanding Embecta Corp.’s stock price such as:

• Embecta Corp.’s current stock price and volume
• Why Embecta Corp.’s stock price changed recently
• Upgrades and downgrades for EMBC from analysts
• EMBC’s stock price momentum as measured by its relative strength

About Embecta Corp. (EMBC)

Before we jump into Embecta Corp.’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

Embecta Corp., a medical device company, provides solutions to improve the health and wellbeing of people living with diabetes in the United States and internationally. The company’s products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient’s diabetes. It primarily sells its products to wholesalers and distributors. The company was formerly known as Berra Newco, Inc. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.

Want to learn more about Embecta Corp.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Embecta Corp..

Embecta Corp.’s Stock Price as of Market Close

As of July 31, 2026, 12:01 PM, CST, Embecta Corp.’s stock price was $3.585.

Embecta Corp. is down 2.05% from its previous closing price of $3.660.

During the last market session, Embecta Corp.’s stock traded between $3.525 and $3.690. Currently, there are approximately 59.30 million shares outstanding for Embecta Corp..

Embecta Corp.’s price-earnings (P/E) ratio is currently at 1.9, which is low compared to the Health Care Equipment & Supplies industry median of 30.5. The price-earnings ratio gauges market expectation of future performance by relating a stock’s current share price to its earnings per share.

Embecta Corp. Stock Price History

Embecta Corp.’s (EMBC) price is currently up 9.97% so far this month.

During the month of July, Embecta Corp.’s stock price has reached a high of $3.750 and a low of $3.070.

Over the last year, Embecta Corp. has hit prices as high as $15.550 and as low as $2.770. Year to date, Embecta Corp.’s stock is down 69.82%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Embecta Corp. Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of July 30, 2026, there were 3 analysts who downgraded Embecta Corp.’s stock and 0 analysts who upgraded over the last month.

Additionally, you'll want to evaluate Embecta Corp.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Embecta Corp.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Embecta Corp.’s current valuation based on AAII’s Value Grade is a A, which means it is considered to be Deep Value.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Embecta Corp. (EMBC) by visiting AAII Stock Evaluator.

Relative Price Strength of Embecta Corp.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of July 30, 2026, Embecta Corp. has a weighted four-quarter relative price strength of -28.10%, which translates to a Momentum Score of 8 and is considered to be Very Weak.

Want to learn more about how Embecta Corp. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Embecta Corp. Stock Price: Bottom Line

As of July 31, 2026, Embecta Corp.’s stock price is $3.585, which is down 2.05% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Embecta Corp. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.